インスリン抵抗性:自然のブロックを回避する

Effect of potassium-magnesium citrate on upper gastrointestinal mucosa.

Alimentary pharmacology & therapeutics·1998

Bronchoalveolar lavage findings suggest two different forms of childhood asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·1998

Rapid method for the simultaneous measurement of nicotine and cotinine in urine and serum by gas chromatography-mass spectrometry.

Journal of chromatography. B, Biomedical sciences and applications·1998

A behavioral intervention for improving verbal behaviors of heroin addicts in a treatment clinic.

Journal of applied behavior analysis·1998

Gamma-hydroxybutyrate (GHB): a new drug of misuse.

Irish medical journal·1998

The Australian mortality decline: cause-specific mortality 1907-1990.

Australian and New Zealand journal of public health·1998

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Advances in green-synthesized quantum dot-based nanoplatforms for cancer treatment, photodynamic therapy, photothermal therapy and cancer theranostics.

RSC advances·2026

Melatonin improves mitochondrial function and redox balance in human cartilage endplate-derived stem cells.

Cytotechnology·2026

Low-dimensional MoS<sub>2</sub> coupled with ZIF-67-derived carbon as an efficient electrocatalyst for the acidic hydrogen evolution reaction.

Chemical communications (Cambridge, England)·2026

Cu/Mn-modulated self-supported Ni catalyst with a hierarchical architecture for efficient ethanol oxidation-coupled hydrogen production.

Nanoscale·2026

Single-particle atomic-scale strain-gradient engineering for high-performance fuel cells.

Nature communications·2026

DGAT2: A Key Therapeutic Target in Lipid Synthesis Regulation and Metabolic Diseases.

European journal of pharmacology·2026

関連する実験動画

インスリン抵抗性:自然のブロックを回避する

関連する概念動画

Effect of potassium-magnesium citrate on upper gastrointestinal mucosa.

Bronchoalveolar lavage findings suggest two different forms of childhood asthma.

Rapid method for the simultaneous measurement of nicotine and cotinine in urine and serum by gas chromatography-mass spectrometry.

A behavioral intervention for improving verbal behaviors of heroin addicts in a treatment clinic.

Gamma-hydroxybutyrate (GHB): a new drug of misuse.

The Australian mortality decline: cause-specific mortality 1907-1990.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Advances in green-synthesized quantum dot-based nanoplatforms for cancer treatment, photodynamic therapy, photothermal therapy and cancer theranostics.

Melatonin improves mitochondrial function and redox balance in human cartilage endplate-derived stem cells.

Low-dimensional MoS<sub>2</sub> coupled with ZIF-67-derived carbon as an efficient electrocatalyst for the acidic hydrogen evolution reaction.

Cu/Mn-modulated self-supported Ni catalyst with a hierarchical architecture for efficient ethanol oxidation-coupled hydrogen production.

Single-particle atomic-scale strain-gradient engineering for high-performance fuel cells.

DGAT2: A Key Therapeutic Target in Lipid Synthesis Regulation and Metabolic Diseases.

関連する実験動画

インスリン抵抗性:自然のブロックを回避する

関連する概念動画

関連記事